| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/29/2005 | US6872391 Nucleotide sequences coding polypeptide for use in the treatment of eating disorders |
| 03/29/2005 | US6872358 Test strip dispenser |
| 03/29/2005 | US6872299 Passive sample detection to initiate timing of an assay |
| 03/29/2005 | US6872298 Determination of sample volume adequacy in biosensor devices |
| 03/29/2005 | US6872291 Measuring carbon dioxide in continuous automotive electrocoating and rinsing process |
| 03/29/2005 | US6872290 Electrochemical gas sensor with passage for receiving gas |
| 03/29/2005 | US6872071 Device for adjusting the oxidation agent/fuel mixture in the feeding pipe of a burner |
| 03/29/2005 | US6871545 System and method for measuring stiffness in standing trees |
| 03/29/2005 | US6871526 Apparatus and method for heat testing canisters |
| 03/29/2005 | CA2258514C Method and arrangement for nondestructive classification |
| 03/29/2005 | CA2195745C Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens |
| 03/29/2005 | CA2168967C Power supply monitor and control for medical instrument |
| 03/29/2005 | CA2167813C Strength determination of sheet materials by ultrasonic testing |
| 03/29/2005 | CA2139667C Methods and diagnostic kits for determining toxicity utilizing bacterial stress promoters fused to reporter genes |
| 03/25/2005 | CA2482093A1 Quantitation of nucleic acids using growth curves |
| 03/24/2005 | WO2005027015A2 Method and system for quantitatively analyzing biological samples |
| 03/24/2005 | WO2005026911A2 Apparatus and method for identifying therapeutic targets using a computer model |
| 03/24/2005 | WO2005026741A2 Non-peptide agonists and antagonists of adrenomedullin and gastrin releasing peptide |
| 03/24/2005 | WO2005026740A1 Methods and kits for the detection of prion diseases |
| 03/24/2005 | WO2005026739A2 Increasing the bioavailability of carotenoids by enzymatic hydrolysis of the corresponding fatty acid esters |
| 03/24/2005 | WO2005026738A2 Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a9 (slc22a9) |
| 03/24/2005 | WO2005026737A2 Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a4 (slc22a4) |
| 03/24/2005 | WO2005026736A2 Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a2 (slc22a2) |
| 03/24/2005 | WO2005026735A2 Differentially expressed tumour-specific polypeptides for use in the diagnosis and treatment of cancer |
| 03/24/2005 | WO2005026734A1 Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a6 (slc22a6) |
| 03/24/2005 | WO2005026733A1 Method and device for detecting feline immunodeficiency virus |
| 03/24/2005 | WO2005026732A1 Antibody-based identification of bacterial phenotypes |
| 03/24/2005 | WO2005026731A1 Combination of anti-hpv-16 and 18 antibodies and uses thereof |
| 03/24/2005 | WO2005026730A2 Multiplex binding and activity assays |
| 03/24/2005 | WO2005026729A2 Improved method and apparatus for aligning microbeads in order to interrogate the same |
| 03/24/2005 | WO2005026728A1 Screening method |
| 03/24/2005 | WO2005026727A1 Methods for measuring peroxisome proliferation and peroxisomal induction |
| 03/24/2005 | WO2005026726A1 Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a7 (slc22a7) |
| 03/24/2005 | WO2005026725A1 Diagnostics and therapeutics for diseases associated with organic antion transporter slc22a8 (slc22a8) |
| 03/24/2005 | WO2005026724A2 Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a5 (slc22a5) |
| 03/24/2005 | WO2005026723A1 Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a1 (slc22a1) |
| 03/24/2005 | WO2005026722A1 Identification of pharmaceutical targets |
| 03/24/2005 | WO2005026721A1 Cell phone breath analyzer |
| 03/24/2005 | WO2005026720A1 Methods and apparatus for characterizing polymeric mixtures |
| 03/24/2005 | WO2005026719A2 Diagnostics and therapeutics for diseases associated with transporter slc22a3 (slc22a3) |
| 03/24/2005 | WO2005026714A1 Cell for measuring biological activities and/or physiological parameters of micro-organisms |
| 03/24/2005 | WO2005026712A1 Gas detector |
| 03/24/2005 | WO2005026702A1 Immunoassay |
| 03/24/2005 | WO2005026694A2 Carbon dioxide nanoelectronic sensor |
| 03/24/2005 | WO2005026692A2 Direct detection method for products of cellular metabolism using tof-sims |
| 03/24/2005 | WO2005026689A2 Immunoassay device with immuno-reference electrode |
| 03/24/2005 | WO2005026688A2 Sampling management for a process analysis tool to minimize sample usage and decrease sampling time |
| 03/24/2005 | WO2005026687A2 Diagnosis and monitoring of hepatocellular carcinoma |
| 03/24/2005 | WO2005026681A2 Magnetostrictive ligand sensor devices and uses thereof |
| 03/24/2005 | WO2005026660A1 Sheet-surface analyser and method of analysing a sheet-surface |
| 03/24/2005 | WO2005026393A2 Biological particulate matter analogue |
| 03/24/2005 | WO2005026383A1 Method and device for determining if a product is in condition for use or consumption |
| 03/24/2005 | WO2005026382A1 Neural colony forming assay |
| 03/24/2005 | WO2005026380A2 Bone marrow proliferation assay |
| 03/24/2005 | WO2005026355A1 Method of evaluating cancerization degree |
| 03/24/2005 | WO2005026354A1 Method of evaluating cancerization degree |
| 03/24/2005 | WO2005026353A1 Method of evaluating cancerization degree |
| 03/24/2005 | WO2005026352A1 Method of evaluating cancerization degree |
| 03/24/2005 | WO2005026351A1 Method of evaluating cancerization degree |
| 03/24/2005 | WO2005026350A1 Method of evaluating cancerization degree |
| 03/24/2005 | WO2005026348A1 Screening method |
| 03/24/2005 | WO2005026336A1 Monoclonal antibody specific for ppar gamma, hybridoma cell line producing the same, and method for detecting regulator related to diseases, including inflammation, cancer and metabolic diseases, using the same |
| 03/24/2005 | WO2005026328A2 Cpt resistant cell line |
| 03/24/2005 | WO2005026321A2 Protein o-sulfonation |
| 03/24/2005 | WO2005026314A2 Group of genes differentially expressed in peripheral blood cells and diagnostic method and assay method using the same |
| 03/24/2005 | WO2005026313A1 Methods and device for adhesive control of internal cell organisation |
| 03/24/2005 | WO2005026208A2 Chimeric gabab receptor |
| 03/24/2005 | WO2005026193A2 Small molecules and a pharmacophore model for inhibition of botulinum toxin and methods of making and using thereof |
| 03/24/2005 | WO2005026192A2 Hpv cd8+ t-cell epitopes |
| 03/24/2005 | WO2005026191A2 Size-controlled macromolecule |
| 03/24/2005 | WO2005026178A2 Electrochemical affinity biosensor system and methods |
| 03/24/2005 | WO2005026172A1 Prostamide receptor antagonists |
| 03/24/2005 | WO2005025651A1 Apheresis device |
| 03/24/2005 | WO2005025618A2 Treatment of rheumatoid arthritis with cd99 antagonists |
| 03/24/2005 | WO2005025607A1 Methods of stimulating innate immunity using cationic peptides |
| 03/24/2005 | WO2005025602A1 METHODS FOR IDENTIFYING MODULATORS OF PROTEIN KINASE C-EPSILON (PKCϵ) AND METHOD OF TREATMENT OF ABERRANT GLUCOSE METABOLISM ASSOCIATED THEREWITH |
| 03/24/2005 | WO2005025592A2 In vivo modulation of neuronal transport |
| 03/24/2005 | WO2005025497A2 Hpv cd8+ t-cell epitopes |
| 03/24/2005 | WO2005025397A1 Toilet apparatus |
| 03/24/2005 | WO2005025310A2 MODEL SYSTEM FOR TCR ξ CHAIN DOWNREGULATION |
| 03/24/2005 | WO2005017531A3 Simultaneous generation of multiple chemiluminescent signals on solid supports |
| 03/24/2005 | WO2005017507A3 Polarization modulation interrogation of grating-coupled waveguide sensors |
| 03/24/2005 | WO2005017192A3 Screening for gestational disorders |
| 03/24/2005 | WO2005015239A3 Method for n-terminal labeling of proteins |
| 03/24/2005 | WO2005012908B1 Method for obtaining a single calibration system used for multiparametric assay of antibodies, preferentially at least anti-gliadin and anti-transglutaminase antibodies |
| 03/24/2005 | WO2005012870A3 Improved aminodextran compositions and conjugates and methods of making and using them |
| 03/24/2005 | WO2005011612A3 Alpha 4 beta 2 delta gaba-a receptors as a strategy for pms and alcoholism |
| 03/24/2005 | WO2005010492A3 Classification of disease states using mass spectrometry data |
| 03/24/2005 | WO2005009581A3 Methods and apparatus for blood separation and analysis using membranes on an optical bio-disc |
| 03/24/2005 | WO2005008213A3 Expression profile algorithm and test for cancer prognosis |
| 03/24/2005 | WO2005007893A3 Universal detection of binding |
| 03/24/2005 | WO2005003785A3 Anti-inflammatory assay and compounds |
| 03/24/2005 | WO2005003297A3 Mptens as modifiers of the pten/igf pathway and methods of use |
| 03/24/2005 | WO2005001026A3 Adks as modifiers of the pten pathway and methods of use |
| 03/24/2005 | WO2005000308A3 Methods of identifying hcv ns5b polymerase inhibitors and use against hepatitis c |
| 03/24/2005 | WO2004111613A3 Fluid sampling components |
| 03/24/2005 | WO2004111601A3 Couette device and method to study solids deposition from flowing fluids |
| 03/24/2005 | WO2004111259A3 Hydrolytic substrates for an analyte-dependent enzyme activation system |
| 03/24/2005 | WO2004111194A3 Method to increase protein production in culture |
| 03/24/2005 | WO2004111186A3 Monitoring for and detecting microbes used in bioterrorism |